Daniel Boaz Zandman MD
Advanced Endoscopic Interventional, Inflammatory Bowel Disease
M.D.
Join to View Full Profile
330 Brookline AveBoston, MA 02215
Phone+1 617-667-7000
Dr. Zandman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Daniel Zandman is a Gastroenterologist based in Cambridge, MA, with subspecialties in Advanced Endoscopic Interventional and Inflammatory Bowel Disease. His medical education includes residencies at the Beth Israel Deaconess Medical Center and the Icahn School of Medicine at Mount Sinai, with a fellowship in Gastroenterology at Brown University. Dr. Zandman is an experienced practitioner in the treatment and management of inflammatory bowel disease, Crohn's disease, ulcerative colitis, and interventional gastroenterology. He has engaged in several notable publications including a frequently cited work in The Journal of Experimental Medicine. In 2013, Dr. Zandman received the CMS Meaningful Use Stage 1 Certification from eClinicalWorks EHR.
Education & Training
Rhode Island Hospital/Brown University HealthFellowship, Gastroenterology, 2010 - 2013
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2007 - 2010
Icahn School of Medicine at Mount SinaiClass of 2007
Certifications & Licensure
MA State Medical License 2013 - 2026
RI State Medical License 2010 - 2013
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013
Publications & Presentations
PubMed
- 1 citationsA Case of Persistent Helicobacter pylori Infection Occurring with Anti-IgE Immunosuppression.Daniel Zandman, William C. Hahn, Steven F. Moss
ACG Case Reports Journal. 2013-10-08 - 2 citationsPatient considerations in the management of ulcerative colitis: role of once-daily MMX mesalamineDaniel B Zandman, Mark A. Peppercorn
Patient Preference and Adherence. 2009-03-26 - 209 citationsNormal B cell homeostasis requires B cell activation factor production by radiation-resistant cells.Leonid Gorelik, Kevin Gilbride, Max Dobles, Susan L. Kalled, Daniel Zandman
The Journal of Experimental Medicine. 2003-09-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
